Boule’s hematology solutions, based on Swedish innovation, are trusted for their robustness and reliability. The objective of the offering is to contribute to a reduced laboratory turnaround time to bring clinical relevance to the decentralized testing segment. Cost-efficiency for our customers enables providing solutions for everyone, everywhere in the world.


Short time to diagnosis and initiation of treatment can increase a patient’s ability to recover from illness. Our analyzers are designed for simple operations to support use under challenging conditions.


Reporting of patient sample results depends on instrument uptime. A robust design that reduces maintenance and service calls ensures instrument availability.


CBC testing is performed in virtually all clinical laboratories, as results support decision-making for further testing and treatment plan. Parameter values, also visualized in histograms, provides valuable clinical insights for use in initial disease investigations.